Article Details

Beckley Psytech raises $80m for psychedelic meds development

Retrieved on: 2021-08-16 14:25:33

Tags for this article:

Click the tags to see associated articles and topics

Beckley Psytech raises $80m for psychedelic meds development. View article details on hiswai:

Excerpt

It was formed in 2019 as the result of a partnership between UK drug research institute The Beckley Foundation and Canopy Growth Corporation.

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up